Skip to main content
Erschienen in: Pediatric Nephrology 1/2013

01.01.2013 | Educational Review

Cystinosis: the evolution of a treatable disease

verfasst von: Galina Nesterova, William A. Gahl

Erschienen in: Pediatric Nephrology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Cystinosis is a rare autosomal recessive disorder involving lysosomal storage of the amino acid cystine due to a defect in the membrane transport protein, cystinosin. Since the introduction of kidney transplants and the availability of cystine-depleting medical therapy, this previously fatal disease was transformed into a treatable disorder. Renal allografts and medical therapy targeting the basic metabolic defect have altered the natural hisotry of cystinosis so drastically that patients have a life expectancy extending past 50 years. Consequently, early diagnosis and appropriate therapy are critically important. In this article, we offer a review of the manifestations of cystinosis, including the proximal tubular dysfunction of renal Fanconi syndrome, and discuss the prevention and treatment of the disorder’s systemic complications. We focus on the nephropathic forms of cystinosis, aiming to assist nephrologists and other physicians to develop early recognition and appropriate management of cystinosis patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Drube J, Schiffer E, Mischak H, Kemper MJ, Neuhaus T, Pape L, Lichtinghagen R, Ehrich JH (2009) Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol Dial Transplant 24(7):2161–2169PubMedCrossRef Drube J, Schiffer E, Mischak H, Kemper MJ, Neuhaus T, Pape L, Lichtinghagen R, Ehrich JH (2009) Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol Dial Transplant 24(7):2161–2169PubMedCrossRef
2.
Zurück zum Zitat Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N Engl J Med 1347:111–121CrossRef Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N Engl J Med 1347:111–121CrossRef
3.
Zurück zum Zitat Anikster Y, Lucero C, Touchman JW, Huizing M, McDowell G, Shotelersuk V, Green ED, Gahl WA (1999) Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab 66:111–116PubMedCrossRef Anikster Y, Lucero C, Touchman JW, Huizing M, McDowell G, Shotelersuk V, Green ED, Gahl WA (1999) Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab 66:111–116PubMedCrossRef
4.
Zurück zum Zitat Gahl WA, Thoene J, Schneider JA (2001) Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B. (eds) The metabolic and molecular basis of inherited disease, Eighth edition. McGraw-Hill Companies, Inc, pp. 5085-5108 Gahl WA, Thoene J, Schneider JA (2001) Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B. (eds) The metabolic and molecular basis of inherited disease, Eighth edition. McGraw-Hill Companies, Inc, pp. 5085-5108
5.
Zurück zum Zitat Kalatzis V, Antignac C (2002) Cystinosis: from gene to disease. Nephrol Dial Transplant 17:1883–1886PubMedCrossRef Kalatzis V, Antignac C (2002) Cystinosis: from gene to disease. Nephrol Dial Transplant 17:1883–1886PubMedCrossRef
6.
Zurück zum Zitat Anikster Y, Lacbawan F, Brantly M, Gochuico BL, Avila NA, Travis W, Gahl WA (2001) Pulmonary dysfunction in adults with nephropathic cystinosis. Chest 119:394–401PubMedCrossRef Anikster Y, Lacbawan F, Brantly M, Gochuico BL, Avila NA, Travis W, Gahl WA (2001) Pulmonary dysfunction in adults with nephropathic cystinosis. Chest 119:394–401PubMedCrossRef
7.
Zurück zum Zitat Thoene J, Lemons R, Anikster Y, Mullet J, Paelicke K, Lucero C, Gahl W, Schneider J, Shu SG, Campbell HT (1999) Mutations of CTNS causing intermediate cystinosis. Mol Genet Metab 7:283–289CrossRef Thoene J, Lemons R, Anikster Y, Mullet J, Paelicke K, Lucero C, Gahl W, Schneider J, Shu SG, Campbell HT (1999) Mutations of CTNS causing intermediate cystinosis. Mol Genet Metab 7:283–289CrossRef
9.
Zurück zum Zitat Gahl WA, Thoene JG, Schneider JA, O’Regan S, Kaiser-Kupfer MI, Kuwabara T (1988) NIH conference - Cystinosis: progress in a prototypic disease. Ann Intern Med 109:557–569PubMed Gahl WA, Thoene JG, Schneider JA, O’Regan S, Kaiser-Kupfer MI, Kuwabara T (1988) NIH conference - Cystinosis: progress in a prototypic disease. Ann Intern Med 109:557–569PubMed
10.
Zurück zum Zitat Pisoni RL, Thoene JG, Christensen HN (1985) Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts: role in therapeutic cystine removal. J Biol Chem 260:4791–4798PubMed Pisoni RL, Thoene JG, Christensen HN (1985) Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts: role in therapeutic cystine removal. J Biol Chem 260:4791–4798PubMed
11.
Zurück zum Zitat Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD (1982) Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 217:1263–1265PubMedCrossRef Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD (1982) Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 217:1263–1265PubMedCrossRef
12.
Zurück zum Zitat Park M, Helip-Wooley A, Thoene J (2002) Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells. J Am Soc Nephrol 13:2878–2887PubMedCrossRef Park M, Helip-Wooley A, Thoene J (2002) Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells. J Am Soc Nephrol 13:2878–2887PubMedCrossRef
13.
Zurück zum Zitat Thoene JG (2007) A review of the role of enhanced apoptosis in the pathophysiology of cystinosis. Mol Genet Metab 92(4):292–298PubMedCrossRef Thoene JG (2007) A review of the role of enhanced apoptosis in the pathophysiology of cystinosis. Mol Genet Metab 92(4):292–298PubMedCrossRef
14.
Zurück zum Zitat Sansanwal P, Yen B, Gahl WA, Ma Y, Ying L, Wong LJ, Sarwal MM (2010) Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol 21(2):272–283PubMedCrossRef Sansanwal P, Yen B, Gahl WA, Ma Y, Ying L, Wong LJ, Sarwal MM (2010) Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol 21(2):272–283PubMedCrossRef
15.
Zurück zum Zitat Park M, Thoene J (2005) Potential role of apoptosis in development of the cystinotic phenotype. Pediatr Nephrol 20:441–446PubMedCrossRef Park M, Thoene J (2005) Potential role of apoptosis in development of the cystinotic phenotype. Pediatr Nephrol 20:441–446PubMedCrossRef
16.
Zurück zum Zitat Larsen CP, Walker PD, Thoene JG (2010) The incidence of atubular glomeruli in nephropathic cystinosis renal biopsies. Mol Genet Metab 101(4):417–420PubMedCrossRef Larsen CP, Walker PD, Thoene JG (2010) The incidence of atubular glomeruli in nephropathic cystinosis renal biopsies. Mol Genet Metab 101(4):417–420PubMedCrossRef
17.
Zurück zum Zitat Cherqui S, Sevin C, Hamard G, Kalatzis V, Sich M, Pequignot MO, Gogat K, Abitbol M, Broyer M, Gubler MC, Antignac C (2002) Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol Cell Bio 22:7622–7632CrossRef Cherqui S, Sevin C, Hamard G, Kalatzis V, Sich M, Pequignot MO, Gogat K, Abitbol M, Broyer M, Gubler MC, Antignac C (2002) Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol Cell Bio 22:7622–7632CrossRef
18.
Zurück zum Zitat Baum M (1998) The Fanconi syndrome of cystinosis: insights into the pathophysiology. Pediatr Nephrol 12:492–497PubMedCrossRef Baum M (1998) The Fanconi syndrome of cystinosis: insights into the pathophysiology. Pediatr Nephrol 12:492–497PubMedCrossRef
19.
Zurück zum Zitat Roth KS, Foreman JW, Segal S (1981) The Fanconi syndrome and mechanisms of tubular transport dysfunction. Kidney Int 20:705–716PubMedCrossRef Roth KS, Foreman JW, Segal S (1981) The Fanconi syndrome and mechanisms of tubular transport dysfunction. Kidney Int 20:705–716PubMedCrossRef
20.
Zurück zum Zitat Baum M (1993) The cellular basis of Fanconi syndrome. Hosp Pract (Off Ed) 28(11):137–142, Review 147-148 Baum M (1993) The cellular basis of Fanconi syndrome. Hosp Pract (Off Ed) 28(11):137–142, Review 147-148
21.
Zurück zum Zitat Theodoropoulos DS, Shawker TH, Heinrichs C, Gahl WA (1995) Medullary nephrocalcinosis in nephropathic cystinosis. Pediatr Nephrol 9:412–418PubMedCrossRef Theodoropoulos DS, Shawker TH, Heinrichs C, Gahl WA (1995) Medullary nephrocalcinosis in nephropathic cystinosis. Pediatr Nephrol 9:412–418PubMedCrossRef
22.
Zurück zum Zitat Winkler L, Offner G, Krull F, Brodehl J (1993) Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr 152:244–249PubMedCrossRef Winkler L, Offner G, Krull F, Brodehl J (1993) Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr 152:244–249PubMedCrossRef
23.
Zurück zum Zitat Bernardini I, Rizzo WB, Dalakas M, Bernar J, Gahl WA (1985) Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest 75:1124–1130PubMedCrossRef Bernardini I, Rizzo WB, Dalakas M, Bernar J, Gahl WA (1985) Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest 75:1124–1130PubMedCrossRef
24.
Zurück zum Zitat Long WS, Seashore MR, Siegel NJ, Bia MJ (1990) Idiopathic Fanconi syndrome with progressive renal failure: a case report and discussion. Yale J Biol Med 63(1):15–28PubMed Long WS, Seashore MR, Siegel NJ, Bia MJ (1990) Idiopathic Fanconi syndrome with progressive renal failure: a case report and discussion. Yale J Biol Med 63(1):15–28PubMed
25.
Zurück zum Zitat Cetinkaya I, Schlatter E, Hirsch JR, Herter P, Harms E, Kleta R (2002) Inhibition of Na+-dependent transporters in cystine-loaded human renal cells: electrophysiological studies on the Fanconi syndrome of cystinosis. J Am Soc Nephrol 13:2085–2093PubMedCrossRef Cetinkaya I, Schlatter E, Hirsch JR, Herter P, Harms E, Kleta R (2002) Inhibition of Na+-dependent transporters in cystine-loaded human renal cells: electrophysiological studies on the Fanconi syndrome of cystinosis. J Am Soc Nephrol 13:2085–2093PubMedCrossRef
26.
Zurück zum Zitat Manz F, Gretz N (1994) Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis. Pediatr Nephrol 8:466–471PubMedCrossRef Manz F, Gretz N (1994) Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis. Pediatr Nephrol 8:466–471PubMedCrossRef
27.
Zurück zum Zitat Middleton R, Bradbury M, Webb N, O’Donoghue D, van’t Hoff W (2003) Cystinosis. A clinicopathological conference. “From toddlers to twenties and beyond” Adult-Paediatric Nephrology Interface Meeting, Manchester 2001. Nephrol Dial Transplant 18:2492–2495PubMedCrossRef Middleton R, Bradbury M, Webb N, O’Donoghue D, van’t Hoff W (2003) Cystinosis. A clinicopathological conference. “From toddlers to twenties and beyond” Adult-Paediatric Nephrology Interface Meeting, Manchester 2001. Nephrol Dial Transplant 18:2492–2495PubMedCrossRef
28.
Zurück zum Zitat Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI (2000) Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab 71:100–120PubMedCrossRef Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI (2000) Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab 71:100–120PubMedCrossRef
29.
Zurück zum Zitat Gahl WA (1986) Cystinosis coming of age. Adv Pediatr 33:95–126PubMed Gahl WA (1986) Cystinosis coming of age. Adv Pediatr 33:95–126PubMed
30.
Zurück zum Zitat Gahl WA, Hubbard VS, Orloff S (1984) Decreased sweat production in cystinosis. J Pediatr 104:904–905PubMedCrossRef Gahl WA, Hubbard VS, Orloff S (1984) Decreased sweat production in cystinosis. J Pediatr 104:904–905PubMedCrossRef
31.
Zurück zum Zitat Chik CL, Friedman A, Merriam GR, Gahl WA (1993) Pituitary testicular function in nephropathic cystinosis. Ann Intern Med 119:568–575PubMed Chik CL, Friedman A, Merriam GR, Gahl WA (1993) Pituitary testicular function in nephropathic cystinosis. Ann Intern Med 119:568–575PubMed
32.
Zurück zum Zitat Dogulu CF, Tsilou E, Rubin B, Fitzgibbon EJ, Kaiser-Kupper MI, Rennert OM, Gahl WA (2004) Idiopathic intracranial hypertension in cystinosis. J Pediatr 145(5):673–678PubMedCrossRef Dogulu CF, Tsilou E, Rubin B, Fitzgibbon EJ, Kaiser-Kupper MI, Rennert OM, Gahl WA (2004) Idiopathic intracranial hypertension in cystinosis. J Pediatr 145(5):673–678PubMedCrossRef
33.
Zurück zum Zitat Broyer M, Tete MJ, Guest G, Bertheleme JP, Labrousse F, Poisson M (1996) Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis 19:65–75PubMedCrossRef Broyer M, Tete MJ, Guest G, Bertheleme JP, Labrousse F, Poisson M (1996) Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis 19:65–75PubMedCrossRef
34.
Zurück zum Zitat Ballantyne AO, Trauner DA (2000) Neurobehavioral consequences of a genetic metabolic disorder: visual processing deficits in infantile nephropathic cystinosis. Neuropsychiatr Neuropsychol Behav Neurol 13:254–263 Ballantyne AO, Trauner DA (2000) Neurobehavioral consequences of a genetic metabolic disorder: visual processing deficits in infantile nephropathic cystinosis. Neuropsychiatr Neuropsychol Behav Neurol 13:254–263
35.
Zurück zum Zitat Nesterova G, Gahl W (2008) Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol 23(6):863–867PubMedCrossRef Nesterova G, Gahl W (2008) Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol 23(6):863–867PubMedCrossRef
36.
Zurück zum Zitat Wühl E, Haffner D, Offner G, Broyer M, van’t Hoff W, Mehls O, European Study Group on Growth Hormone Treatment in Children with Nephropathic Cystinosis (2001) Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr 138:880–887PubMedCrossRef Wühl E, Haffner D, Offner G, Broyer M, van’t Hoff W, Mehls O, European Study Group on Growth Hormone Treatment in Children with Nephropathic Cystinosis (2001) Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr 138:880–887PubMedCrossRef
37.
Zurück zum Zitat Schnaper HW, Cottel J, Merrill S, Marcusson E, Kissane JM, Shackelford GD, So SK, Nelson RD, Cole BR, Smith ML, Schneider JA (1992) Early occurrence of end-stage renal disease in a patient with infantile nephropathic cystinosis. J Pediatr 120(4 Pt 1):575–578PubMed Schnaper HW, Cottel J, Merrill S, Marcusson E, Kissane JM, Shackelford GD, So SK, Nelson RD, Cole BR, Smith ML, Schneider JA (1992) Early occurrence of end-stage renal disease in a patient with infantile nephropathic cystinosis. J Pediatr 120(4 Pt 1):575–578PubMed
38.
Zurück zum Zitat Mahoney CP, Striker GE (2000) Early development of the renal lesions in infantile cystinosis. Pediatr Nephrol 15:50–56PubMedCrossRef Mahoney CP, Striker GE (2000) Early development of the renal lesions in infantile cystinosis. Pediatr Nephrol 15:50–56PubMedCrossRef
39.
Zurück zum Zitat Gahl WA, Balog JZ, Kleta R (2007) Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intl Med 147(4):242–250 Gahl WA, Balog JZ, Kleta R (2007) Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intl Med 147(4):242–250
40.
Zurück zum Zitat Almond PS, Matas AJ, Nakhleh RE, Morel P, Troppmann C, Najarian JS, Chavers B (1993) Renal transplantation for infantile cystinosis: long-term follow-up. J Pediatr Surg 28:232–238PubMedCrossRef Almond PS, Matas AJ, Nakhleh RE, Morel P, Troppmann C, Najarian JS, Chavers B (1993) Renal transplantation for infantile cystinosis: long-term follow-up. J Pediatr Surg 28:232–238PubMedCrossRef
41.
Zurück zum Zitat Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman CB, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby F, Sonies BC, Thoene JG, Trauner DA, Gahl WA, NIH Office of Rare Diseases (2005) First NIH/Office of Rare Diseases Conference on cystinosis: past, present, and future. Pediatr Nephrol 20:452–454PubMedCrossRef Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman CB, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby F, Sonies BC, Thoene JG, Trauner DA, Gahl WA, NIH Office of Rare Diseases (2005) First NIH/Office of Rare Diseases Conference on cystinosis: past, present, and future. Pediatr Nephrol 20:452–454PubMedCrossRef
42.
Zurück zum Zitat Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA (2004) Long-term follow-up of well treated nephropathic cystinosis patients. J Pediatr 145:555–560PubMedCrossRef Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA (2004) Long-term follow-up of well treated nephropathic cystinosis patients. J Pediatr 145:555–560PubMedCrossRef
43.
Zurück zum Zitat Markello TC, Bernardini IM, Gahl WA (1993) Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328:1157–1162PubMedCrossRef Markello TC, Bernardini IM, Gahl WA (1993) Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328:1157–1162PubMedCrossRef
44.
Zurück zum Zitat Tsilou ET, Rubin BI, Reed G, Caruso RC, Iwata F, Balog J, Gahl WA, Kaiser-Kupfer MI (2006) Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy. Ophthalmology 113:1002–1009PubMedCrossRef Tsilou ET, Rubin BI, Reed G, Caruso RC, Iwata F, Balog J, Gahl WA, Kaiser-Kupfer MI (2006) Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy. Ophthalmology 113:1002–1009PubMedCrossRef
45.
Zurück zum Zitat Charnas LR, Luciano CA, Dalakas M, Gilliatt RW, Bernardini I, Ishak K, Cwik VA, Fraker D, Brushart TA, Gahl WA (1994) Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol 35(2):181–188PubMedCrossRef Charnas LR, Luciano CA, Dalakas M, Gilliatt RW, Bernardini I, Ishak K, Cwik VA, Fraker D, Brushart TA, Gahl WA (1994) Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol 35(2):181–188PubMedCrossRef
46.
Zurück zum Zitat Trauner DA, Fahmy RF, Mishler DA (2001) Oral motor dysfunction and feeding difficulties in nephropathic cystinosis. Pediatr Neurol 24:365–368PubMedCrossRef Trauner DA, Fahmy RF, Mishler DA (2001) Oral motor dysfunction and feeding difficulties in nephropathic cystinosis. Pediatr Neurol 24:365–368PubMedCrossRef
47.
Zurück zum Zitat Zimakas PJ, Sharma AK, Rodd CJ (2003) Osteopenia and fractures in cystinotic children post renal transplantation. Pediatr Nephrol 18:384–390PubMed Zimakas PJ, Sharma AK, Rodd CJ (2003) Osteopenia and fractures in cystinotic children post renal transplantation. Pediatr Nephrol 18:384–390PubMed
48.
Zurück zum Zitat Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA (2005) Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Med (Baltimore) 84:137–146CrossRef Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA (2005) Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Med (Baltimore) 84:137–146CrossRef
49.
Zurück zum Zitat O’Brien K, Hussain N, Warady BA, Kleiner DE, Kleta R, Bernardini I, Heller T, Gahl WA (2006) Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. Clin Gastroenterol Hepatol 4:387–394PubMedCrossRef O’Brien K, Hussain N, Warady BA, Kleiner DE, Kleta R, Bernardini I, Heller T, Gahl WA (2006) Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. Clin Gastroenterol Hepatol 4:387–394PubMedCrossRef
50.
Zurück zum Zitat Treem WR, Rusnack EJ, Ragsdale BD, Seikaly MG, DiPalma JS (1988) Inflammatory bowel disease in a patient with nephropathic cystinosis. Pediatrics 81:584–587PubMed Treem WR, Rusnack EJ, Ragsdale BD, Seikaly MG, DiPalma JS (1988) Inflammatory bowel disease in a patient with nephropathic cystinosis. Pediatrics 81:584–587PubMed
51.
Zurück zum Zitat Robert JJ, Tête MJ, Guest G, Gagnadoux MF, Niaudet P, Broyer M (1999) Diabetes mellitus in patients with infantile cystinosis after renal transplantation. Pediatr Nephrol 13(6):524–529PubMedCrossRef Robert JJ, Tête MJ, Guest G, Gagnadoux MF, Niaudet P, Broyer M (1999) Diabetes mellitus in patients with infantile cystinosis after renal transplantation. Pediatr Nephrol 13(6):524–529PubMedCrossRef
52.
Zurück zum Zitat Broyer M, Guillot M, Gubler MC, Habib R (1981) Infantile cystinosis: a reappraisal of early and late symptoms. Adv Nephrol Necker Hosp 10:137–166PubMed Broyer M, Guillot M, Gubler MC, Habib R (1981) Infantile cystinosis: a reappraisal of early and late symptoms. Adv Nephrol Necker Hosp 10:137–166PubMed
53.
Zurück zum Zitat Dixit MP, Greifer I (2002) Nephropathic cystinosis associated with cardiomyopathy: a 27-year clinical follow-up. BMC Nephrol 3:8PubMedCrossRef Dixit MP, Greifer I (2002) Nephropathic cystinosis associated with cardiomyopathy: a 27-year clinical follow-up. BMC Nephrol 3:8PubMedCrossRef
54.
Zurück zum Zitat Ueda M, O’Brien K, Rosing D, Ling A, Kleta R, McAreavey D, Bernardini I, Gahl W (2006) Coronary artery and other vascular calcifications in patients with cystinosis after kidney transplantation. Clin J Am Soc Nephrol 1:555–562PubMedCrossRef Ueda M, O’Brien K, Rosing D, Ling A, Kleta R, McAreavey D, Bernardini I, Gahl W (2006) Coronary artery and other vascular calcifications in patients with cystinosis after kidney transplantation. Clin J Am Soc Nephrol 1:555–562PubMedCrossRef
55.
Zurück zum Zitat Hulton SA, Keffler S, Green A, Taylor CM (1994) Serum cholesterol in children with cystinosis. Abstracts of 32nd Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Edinburgh pg 108 Hulton SA, Keffler S, Green A, Taylor CM (1994) Serum cholesterol in children with cystinosis. Abstracts of 32nd Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Edinburgh pg 108
56.
Zurück zum Zitat Olgar S, Nisli K, Dindar A, Omeroglu RE, Ertugrul T (2006) Can cystinosis cause coronary artery dilatation? Pediatr Cardiol 27:263–268PubMedCrossRef Olgar S, Nisli K, Dindar A, Omeroglu RE, Ertugrul T (2006) Can cystinosis cause coronary artery dilatation? Pediatr Cardiol 27:263–268PubMedCrossRef
57.
Zurück zum Zitat Olcay L, Erdemli E, KesimerM BY, Okur H, Kalkanoðlu HS, Coskun T, Altay C (2005) High cystine in platelets from patients with nephropathic cystinosis: a chemical, ultrastructural, and functional evaluation. J Clin Pathol 58:939–945PubMedCrossRef Olcay L, Erdemli E, KesimerM BY, Okur H, Kalkanoðlu HS, Coskun T, Altay C (2005) High cystine in platelets from patients with nephropathic cystinosis: a chemical, ultrastructural, and functional evaluation. J Clin Pathol 58:939–945PubMedCrossRef
58.
Zurück zum Zitat Quinn JP, Royston D, Murphy PT (2004) Bone marrow findings in hereditary cystinosis with renal failure. Am J Hematol 76:79PubMedCrossRef Quinn JP, Royston D, Murphy PT (2004) Bone marrow findings in hereditary cystinosis with renal failure. Am J Hematol 76:79PubMedCrossRef
59.
Zurück zum Zitat Lucky AW, Howley PM, Megyesi K, Spielberg SP, Schulman JD (1977) Endocrine studies in cystinosis: compensated primary hypothyroidism. J Pediatr 91:204–210PubMedCrossRef Lucky AW, Howley PM, Megyesi K, Spielberg SP, Schulman JD (1977) Endocrine studies in cystinosis: compensated primary hypothyroidism. J Pediatr 91:204–210PubMedCrossRef
60.
Zurück zum Zitat Kleta R, Gahl WA (2002) Cystinosis: antibodies and healthy bodies. J Am Soc Nephrol 13:2189–2191PubMedCrossRef Kleta R, Gahl WA (2002) Cystinosis: antibodies and healthy bodies. J Am Soc Nephrol 13:2189–2191PubMedCrossRef
61.
Zurück zum Zitat Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesselman JJ, Corden BJ, Schneider JA (1987) Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316:971–977PubMedCrossRef Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesselman JJ, Corden BJ, Schneider JA (1987) Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316:971–977PubMedCrossRef
62.
Zurück zum Zitat Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman CB, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby F, Sonies BC, Thoene JG, Trauner DA, Gahl WA (2005) First NIH/office of rare diseases conference on cystinosis: past, present, and future. Pediatr Nephrol 20(4):452–454PubMedCrossRef Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman CB, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby F, Sonies BC, Thoene JG, Trauner DA, Gahl WA (2005) First NIH/office of rare diseases conference on cystinosis: past, present, and future. Pediatr Nephrol 20(4):452–454PubMedCrossRef
63.
Zurück zum Zitat Kleta R, Gahl WA (2004) Pharmacological treatment of nephropathic cystinosis with cysteamine. Expert Opin Pharmacother 5:2255–2262PubMedCrossRef Kleta R, Gahl WA (2004) Pharmacological treatment of nephropathic cystinosis with cysteamine. Expert Opin Pharmacother 5:2255–2262PubMedCrossRef
64.
Zurück zum Zitat Vilaseca MA, Camacho JA, Briones P, Farré C, Mas A (1995) Biochemical follow-up in late-treated nephropathic cystinosis. J Inherit Metab Dis 18:147–150PubMedCrossRef Vilaseca MA, Camacho JA, Briones P, Farré C, Mas A (1995) Biochemical follow-up in late-treated nephropathic cystinosis. J Inherit Metab Dis 18:147–150PubMedCrossRef
65.
Zurück zum Zitat Theodoropoulos DS, Krasnewich D, Kaiser-Kupfer MI, Gahl WA (1993) Classic nephropathic cystinosis as an adult disease. JAMA 270:2200–2204PubMedCrossRef Theodoropoulos DS, Krasnewich D, Kaiser-Kupfer MI, Gahl WA (1993) Classic nephropathic cystinosis as an adult disease. JAMA 270:2200–2204PubMedCrossRef
66.
Zurück zum Zitat Gahl WA, Schneider JA, Schulman JD, Thoene JG, Reed GF (1990) Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine. Pediatr Nephrol 4:129–135PubMedCrossRef Gahl WA, Schneider JA, Schulman JD, Thoene JG, Reed GF (1990) Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine. Pediatr Nephrol 4:129–135PubMedCrossRef
67.
Zurück zum Zitat Attard M, Jean G, Forestier L, Cherqui S, van’t Hoff W, Broyer M, Antignac C, Town M (1999) Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet 8:2507–2514PubMedCrossRef Attard M, Jean G, Forestier L, Cherqui S, van’t Hoff W, Broyer M, Antignac C, Town M (1999) Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet 8:2507–2514PubMedCrossRef
68.
Zurück zum Zitat Syres K, Harrison F, Tadlock M, Jester JV, Simpson J, Roy S, Salomon DR, Cherqui S (2009) Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 114(12):2542–2552PubMedCrossRef Syres K, Harrison F, Tadlock M, Jester JV, Simpson J, Roy S, Salomon DR, Cherqui S (2009) Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 114(12):2542–2552PubMedCrossRef
69.
Zurück zum Zitat Haase M, Morgera S, Bamberg C, Halle H, Martini S, Dragun D, Neumayer H-H, Budde K (2006) Successful pregnancies in dialysis patients including those suffering from cystinosis and familial Mediterranean fever. J Nephrol 19:677–681PubMed Haase M, Morgera S, Bamberg C, Halle H, Martini S, Dragun D, Neumayer H-H, Budde K (2006) Successful pregnancies in dialysis patients including those suffering from cystinosis and familial Mediterranean fever. J Nephrol 19:677–681PubMed
70.
Zurück zum Zitat Beckman DA, Mullin JJ, Assadi FK (1998) Developmental toxicity of cysteamine in the rat: effects on embryo-fetal development. Teratology 58:96–102PubMedCrossRef Beckman DA, Mullin JJ, Assadi FK (1998) Developmental toxicity of cysteamine in the rat: effects on embryo-fetal development. Teratology 58:96–102PubMedCrossRef
71.
Zurück zum Zitat Gahl WA (1997) Consultation with the Specialist: nephropathic cystinosis. Pediatr Rev 18:302–304PubMedCrossRef Gahl WA (1997) Consultation with the Specialist: nephropathic cystinosis. Pediatr Rev 18:302–304PubMedCrossRef
73.
Zurück zum Zitat Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G, Ottolenghi C, Charbit M, Moyse D, Legendre C, Lesavre P, Cochat P (2012) Servais ACysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int 81(2):179–189PubMedCrossRef Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G, Ottolenghi C, Charbit M, Moyse D, Legendre C, Lesavre P, Cochat P (2012) Servais ACysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int 81(2):179–189PubMedCrossRef
Metadaten
Titel
Cystinosis: the evolution of a treatable disease
verfasst von
Galina Nesterova
William A. Gahl
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 1/2013
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-012-2242-5

Weitere Artikel der Ausgabe 1/2013

Pediatric Nephrology 1/2013 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.